XML 131 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair value measurement
12 Months Ended
Dec. 31, 2012
Fair value measurement

Note 11 — Fair value measurement

The following tables provide the financial assets and liabilities carried at fair value measured on a recurring basis as of December 31, 2012 and December 31, 2011:

 

     Total
carrying
value at
December 31,
2012
     Quoted prices in
active markets
(Level 1)
     Significant
other
observable
inputs (Level 2)
     Significant
unobservable
inputs (Level 3)
 
     (Dollars in thousands)  

Investments in marketable securities

   $ 4,785       $ 4,785       $       $   

Derivative assets

     1,279                 1,279           

Derivative liabilities

     598                 598           

Contingent consideration liabilities

     51,196                         51,196   
     Total
carrying
value at
December 31,
2011
     Quoted prices in
active markets
(Level 1)
     Significant
other
observable
inputs (Level 2)
     Significant
unobservable
inputs (Level 3)
 
     (Dollars in thousands)  

Cash and cash equivalents

   $ 40,005       $ 40,005       $       $   

Bonds — foreign government

     880         880                   

Investments in marketable securities

     4,189         4,189                   

Derivative assets

     204                 204           

Derivative liabilities

     633                 633           

Contingent consideration liabilities

     9,676                         9,676   

 

The following table provides a reconciliation of changes in Level 3 financial liabilities measured at fair value on a recurring basis for the years ended December 31, 2012 and December 31, 2011:

 

     Contingent
consideration
 
     2012     2011  
     (Dollars in thousands)  

Beginning balance

   $ 9,676      $   

Initial estimate upon acquisition

     58,895        15,400   

Payment

     (18,426     (6,000

Revaluations

     1,055        276   

Translation adjustment

     (4       
  

 

 

   

 

 

 

Ending balance

   $ 51,196      $ 9,676   
  

 

 

   

 

 

 

See Note 9, “Borrowings,” for a discussion of the fair value of the Company’s long-term debt.

Valuation Hierarchy

The Derivatives and Hedging Standard under the FASB accounting standards codification establishes a valuation hierarchy of the inputs (i.e. assumptions that market participants would use in pricing an asset or liability) used to measure fair value. This hierarchy prioritizes the inputs into three broad levels as follows:

Level 1 inputs — quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.

Level 2 inputs — inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified (contractual) term, a Level 2 input must be observable for substantially the full term of the asset or liability. Level 2 inputs include:

 

  1. Quoted prices for similar assets or liabilities in active markets.

 

  2. Quoted prices for identical or similar assets or liabilities in markets that are not active.

 

  3. Inputs other than quoted prices that are observable for the asset or liability.

 

  4. Inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 inputs — unobservable inputs for the asset or liability. Unobservable inputs may be used to measure fair value only when observable inputs are not available. Unobservable inputs reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability in achieving the fair value measurement objective of an exit price perspective. An exit price is the price that would be received to sell an asset or paid to transfer a liability.

A financial asset or liability’s classification within the hierarchy is determined based on the lowest level input that is significant to the fair value measurement.

Valuation Techniques Used to Determine Fair Value

The Company’s cash and cash equivalents valued based upon Level 1 inputs are comprised of overnight investments in money market funds. The funds invest in obligations of the U.S. Treasury, including Treasury bills, bonds and notes. The funds seek to maintain a net asset value of $1.00 per share.

 

The Company’s financial assets valued based upon Level 1 inputs are comprised of investments in marketable securities held in trust, which are available to pay benefits under certain deferred compensation plans and other compensatory arrangements. The investment assets of the trust are valued using quoted market prices.

The Company’s financial assets and liabilities valued based upon Level 2 inputs are comprised of foreign exchange contracts. The Company uses foreign exchange contracts to manage foreign currency transaction exposure. The fair value of the foreign exchange contracts represents the amount required to enter into offsetting contracts with similar remaining maturities based on quoted market prices. The Company has taken into account the creditworthiness of the counterparties in measuring fair value. See Note 10, “Financial instruments” for additional information.

During 2011, the Company received $9.6 million of zero-coupon Greek government bonds (the “Greek Bonds”) in settlement of trade receivables due to the Company from sales to the public hospital system in Greece for 2007, 2008 and 2009. Initially, the Company reported the Greek Bonds as a Level 1 financial asset based on quoted prices for identical assets in active markets. As the year progressed, the market activity slowed for these bonds and the Company changed the status of the Greek Bonds to Level 2 based on quoted prices for identical assets. During the fourth quarter of 2011, the Company sold a large portion of the bonds and sold the remainder of the bonds in January 2012. At December 31, 2011, the fair value of the Greek Bonds recorded on the Company’s balance sheet was approximately $0.9 million, which represented the final value received from the January 2012 sale of the remaining bonds. Since the fair value represented a quoted price based on the final sales price of the Greek Bonds, the Company has changed the status of the Greek Bonds back to a Level 1 financial asset.

The Company’s financial liabilities valued based upon Level 3 inputs are comprised of contingent consideration arrangements pertaining to the Company’s acquisitions. The Company accounts for contingent consideration in accordance with applicable accounting guidance pertaining to business combinations. The Company is contractually obligated to pay contingent consideration upon the achievement of specified objectives, including regulatory approvals, sales targets and, in some instances, the passage of time, referred to as milestone payments, and therefore recorded contingent consideration liabilities at the time of the acquisitions. The Company updates its assumptions each reporting period based on new developments and records such amounts at fair value based on the revised assumptions, until such consideration is satisfied through payment upon the achievement of the specified objectives or eliminated upon failure to achieve the specified objectives.

It is estimated that milestone payments will occur in 2013 and may extend until 2018 or later. As of December 31, 2012, the range of undiscounted amounts the Company could be required to pay for contingent consideration arrangements is between $7.0 million and $94.4 million. The Company has determined the fair value of the liabilities for the contingent consideration based on a probability-weighted discounted cash flow analysis. This fair value measurement is based on significant inputs not observable in the market and thus represents a Level 3 measurement within the fair value hierarchy. The fair value of the contingent consideration liability associated with future milestone payments was based on several factors including:

 

   

estimated cash flows projected from the success of market launches;

 

   

the estimated time and resources needed to complete the development of the acquired technologies;

 

   

the uncertainty of obtaining regulatory approvals within the required time periods; and

 

   

the risk adjusted discount rate for fair value measurement.

 

The following table provides information regarding the valuation techniques and inputs used in determining the fair value of assets or liabilities categorized as Level 3 measurements:

 

   

Valuation Technique

 

Unobservable Input

  Range (Weighted Average)  

Contingent consideration

  Discounted cash flow   Discount rate     2.8% - 10%(6%)   
    Probability of payment     0-100%(60%)   

As of December 31, 2012, of the $51.2 million of total contingent consideration, the Company has recorded approximately $23.7 million in Current portion of contingent consideration and the remaining $27.5 million in Other liabilities.